Such evidence has been recently corroborated by results of a post-hoc analysis of the CANVAS study: in patients with type 2 diabetes and albuminuria, baseline TNFR1 and 2 levels predicted CKD progression over time (169). Here, TNFRSF1A is linked to chronic kidney disease.